The Measurement to Understand Reclassification of Disease of Cabarrus/Kannapolis (MURDOCK) Study Community Registry and Biorepository.

Current understanding of chronic diseases is based on crude clinical characterization, imaging studies, and laboratory testing that has evolved over decades. The Measurement to Understand Reclassification of Disease of Cabarrus/Kannapolis (MURDOCK) Study is a multi-tiered, longitudinal study designed to enable classification of chronic diseases using clinically annotated biospecimen collections, -omic technologies, electronic health records, and standard epidemiological methods. We expect that detailed molecular classification will improve mechanistic understanding of chronic diseases, augmenting discovery and testing of new treatments, and allowing refined selection of prevention and treatment strategies. The MURDOCK Study Community Registry and Biorepository will serve as a bridge for validation of initial exploratory studies, a platform for future prospective studies in targeted populations, and a resource of both data (analytical and clinical) and samples for cross-registry meta-analyses and comparative population studies. Participation of local health care providers and the Cabarrus County/Kannapolis, NC, community will facilitate future medical research and provide the opportunity to educate and inform the public about genomic research, actively engaging them in shaping the future of medical discovery and treatment of chronic diseases. We present the rationale and study design for the MURDOCK Community Registry and Biorepository and baseline characteristics of the first 6000 participants.

[1]  Rowena J Dolor,et al.  The MURDOCK Study: a long-term initiative for disease reclassification through advanced biomarker discovery and integration with electronic health records. , 2012, American journal of translational research.

[2]  R. Sacco.  The new American Heart Association 2020 goal: achieving ideal cardiovascular health , 2011, Journal of cardiovascular medicine.

[3]  Eric Boerwinkle,et al.  The Atherosclerosis Risk in Communities (ARIC) Study , 2011 .

[4]  Wendy A. Wolf,et al.  The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studies , 2011, BMC Medical Genomics.

[5]  D. Mozaffarian,et al.  Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.

[6]  David J. Carey,et al.  Electronic Medical Records in Genomic Medicine Practice and Research , 2010 .

[7]  Kevin B. Johnson,et al.  Categorizing the world of registries , 2008, J. Biomed. Informatics.

[8]  K. Lunetta.  Genetic Association Studies , 2008, Circulation.

[9]  Michael W. Link,et al.  A Comparison of Address-Based Sampling (ABS) Versus Random-Digit Dialing (RDD) for General Population Surveys , 2008 .

[10]  Geoffrey S Ginsburg,et al.  Centralized biorepositories for genetic and genomic research. , 2008, JAMA.

[11]  T. Manolio,et al.  How to Interpret a Genome-wide Association Study Topic Collections , 2022 .

[12]  Nan Rothrock,et al.  Evaluation of Item Candidates: The PROMIS Qualitative Item Review , 2007, Medical care.

[13]  Michael W. Link,et al.  Address-based versus random-digit-dial surveys: comparison of key health and risk indicators. , 2006, American journal of epidemiology.

[14]  Mark A Hlatky,et al.  Practice of Epidemiology Validation of a New Brief Physical Activity Survey among Men and Women Aged 60 – 69 Years , 2006 .

[15]  C. McCarty,et al.  Marshfield Clinic Personalized Medicine Research Project (PMRP): design, methods and recruitment for a large population-based biobank. , 2005, Personalized medicine.

[16]  Tim Sprosen,et al.  UK Biobank: from concept to reality. , 2005, Pharmacogenomics.

[17]  A. Petersen.  Securing our genetic health: engendering trust in UK Biobank. , 2005, Sociology of health & illness.

[18]  Ronald M Peshock,et al.  The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. , 2004, The American journal of cardiology.

[19]  Garnet L Anderson,et al.  The Women's Health Initiative recruitment methods and results. , 2003, Annals of epidemiology.

[20]  Virginia Barbour,et al.  UK Biobank: a project in search of a protocol? , 2003, The Lancet.

[21]  M. Fouad,et al.  Recruitment and retention of minority women in cancer screening, prevention, and treatment trials. , 2000, Annals of epidemiology.

[22]  C B Granger,et al.  Risk stratification and therapeutic decision making in acute coronary syndromes. , 2000, JAMA.

[23]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[24]  L. Elveback,et al.  Coronary heart disease in residents of Rochester, Minnesota, 1950-1975. I. Background and study design. , 1981, Mayo Clinic proceedings.

[25]  W. Kannel,et al.  The Framingham Offspring Study. Design and preliminary data. , 1975, Preventive medicine.

[26]  T. Dawber,et al.  Epidemiological approaches to heart disease: the Framingham Study. , 1951, American journal of public health and the nation's health.